The Metabolic Syndrome in Men study: A resource for studies of metabolic & cardiovascular diseases

Journal of Lipid Research

Volumn 58, Issue 3, 2017, Pages 481-493

  Laakso, Markku ^a,b   Kuusisto, Johanna ^a,b   Stančáková, Alena ^a   Kuulasmaa, Teemu ^a   Pajukanta, Päivi ^c,d   Lusis, Aldons J ^c   Collins, Francis S ^e   Mohlke, Karen L ^f   Boehnke, Michael ^g  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cardiovascular risk factors; Coronary artery disease; Metabolic disease; Metsim; Type 2 diabetes

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; DESMOSTEROL; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BIOPSY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE COURSE; FECES ANALYSIS; FINN (CITIZEN); FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLOMICS; NONALCOHOLIC FATTY LIVER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREDICTIVE VALUE; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; RISK FACTOR; TRANSCRIPTOMICS; WHOLE GENOME SEQUENCING; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GLUCOSE TOLERANCE TEST; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; METABOLISM; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOSE TISSUE; AGED; BIOPSY; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; GLUCOSE TOLERANCE TEST; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPERGLYCEMIA; MALE; METABOLIC SYNDROME X; METABOLOMICS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 85014332338     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.O072629     Document Type: Article

References (100)

1. Lim, E. T., P. Wurtz, A. S. Havulinna, P. Palta, T. Tukiainen, K. Rehnstrom, T. Esko, R. Magi, M. Inouye, T. Lappalainen, et al. 2014. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 10: E1004494.
2. Lek, M., K. J. Karczewski, E. V. Minikel, K. E. Samocha, E. Banks, T. Fennell, A. H. O'Donnell-Luria, J. S. Ware, A. J. Hill, B. B. Cummings, et al. 2016. Analysis of protein-coding genetic variation in 60, 706 humans. Nature. 536: 285-291.
3. Stancáková, A., M. Javorský, T. Kuulasmaa, S. M. Haffner, J. Kuusisto, and M. Laakso. 2009. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6, 414 Finnish men. Diabetes. 58: 1212-1221.
4. Lindström, J., and J. Tuomilehto. 2003. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care. 26: 725-731.
5. Stančáková, A., J. Paananen, P. Soininen, A. J. Kangas, L. L. Bonnycastle, M. A. Morken, F. S. Collins, A. U. Jackson, M. L. Boehnke, J. Kuusisto, et al. 2011. Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6, 580 nondiabetic Finnish men. Diabetes. 60: 1608-1616.
6. Laakso, M., J. Zilinskaite, T. Hansen, T. W. Boesgaard, M. Vanttinen, A. Stancakova, P. A. Jansson, F. Pellme, J. J. Holst, T. Kuulasmaa, et al; EUGENE2 Consortium. 2008. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia. 51: 502-511.
7. Thygesen, K., J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman, and H. D. White; Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. 2012. Third universal definition of myocardial infarction. Glob. Heart. 7: 275-295.
8. European Stroke Initiative Executive Committee; EUSI Writing Committee, T. S. Olsen, P. Langhorne, H. C. Diener, M. Hennerici, J. Ferro, J. Sivenius, N. G. Wahlgren, and P. Bath. 2003. European Stroke Initiative recommendations for stroke management-update 2003. Cerebrovasc. Dis. 16: 311-337.
9. Huyghe, J. R., A. U. Jackson, M. P. Fogarty, M. L. Buchkovich, A. Stancakova, H. M. Stringham, X. Sim, L. Yang, C. Fuchsberger, H. Cederberg, et al. 2013. Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat. Genet. 45: 197-201.
10. Gusev, A., A. Ko, H. Shi, G. Bhatia, W. Chung, B. W. Penninx, R. Jansen, E. J. de Geus, D. I. Boomsma, F. A. Wright, et al. 2016. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48: 245-252.
11. Laakso, M., and J. Kuusisto. 2014. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10: 293-302.
12. Stancáková, A., M. Civelek, N. K. Saleem, P. Soininen, A. J. Kangas, H. Cederberg, J. Paananen, J. Pihlajamaki, L. L. Bonnycastle, M. A. Morken, et al. 2012. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9, 369 Finnish men. Diabetes. 61: 1895-1902.
13. Wang, T. J., M. G. Larson, R. S. Vasan, S. Cheng, E. P. Rhee, E. McCabe, G. D. Lewis, C. S. Fox, P. F. Jacques, C. Fernandez, et al. 2011. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17: 448-453.
14. Mahendran, Y., J. Vangipurapu, H. Cederberg, A. Stancakova, J. Pihlajamaki, P. Soininen, A. J. Kangas, J. Paananen, M. Civelek, N. K. Saleem, et al. 2013. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9, 398 Finnish men. Diabetes. 62: 3618-3626.
15. Cederberg, H., H. Gylling, T. A. Miettinen, J. Paananen, J. Vangipurapu, J. Pihlajamaki, T. Kuulasmaa, A. Stancakova, U. Smith, J. Kuusisto, et al. 2013. Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men. PLoS One. 8: E67406.
16. Mahendran, Y., H. Cederberg, J. Vangipurapu, A. J. Kangas, P. Soininen, J. Kuusisto, M. Uusitupa, M. Ala-Korpela, and M. Laakso. 2013. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care. 36: 3732-3738.
17. Lankinen, M. A., A. Stancakova, M. Uusitupa, J. Agren, J. Pihlajamaki, J. Kuusisto, U. Schwab, and M. Laakso. 2015. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia. 58: 2533-2544.
18. Mahendran, Y., J. Agren, M. Uusitupa, H. Cederberg, J. Vangipurapu, A. Stancakova, U. Schwab, J. Kuusisto, and M. Laakso. 2014. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am. J. Clin. Nutr. 99: 79-85.
19. Vangipurapu, J., A. Stancakova, T. Kuulasmaa, J. Kuusisto, and M. Laakso. 2015. Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: A population-based study of 9, 396 Finnish men. PLoS One. 10: E0124028.
20. Fizelova, M., M. Miilunpohja, A. J. Kangas, P. Soininen, J. Kuusisto, M. Ala-Korpela, M. Laakso, and A. Stancakova. 2015. Associations of multiple lipoprotein and apolipoprotein measures with worsening of glycemia and incident type 2 diabetes in 6607 non-diabetic Finnish men. Atherosclerosis. 240: 272-277.
21. Lallukka, S., and H. Yki-Jarvinen. 2016. Non-Alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 30: 385-395.
22. Pihlajamäki, J., T. Kuulasmaa, D. Kaminska, M. Simonen, V. Karja, S. Gronlund, P. Kakela, M. Paakkonen, S. Kainulainen, K. Punnonen, et al. 2012. Serum interleukin 1 receptor antagonist as an independent marker of non-Alcoholic steatohepatitis in humans. J. Hepatol. 56: 663-670.
23. Simonen, M., V. Mannisto, J. Leppanen, D. Kaminska, V. Karja, S. Venesmaa, P. Kakela, J. Kuusisto, H. Gylling, M. Laakso, et al. 2013. Desmosterol in human nonalcoholic steatohepatitis. Hepatology. 58: 976-982.
24. Deeb, S. S., L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen, J. Kuusisto, M. Laakso, W. Fujimoto, and J. Auwerx. 1998. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20: 284-287.
25. Altshuler, D., J. N. Hirschhorn, M. Klannemark, C. M. Lindgren, M. C. Vohl, J. Nemesh, C. R. Lane, S. F. Schaffner, S. Bolk, C. Brewer, et al. 2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26: 76-80.
26. Heikkinen, S., C. Argmann, J. N. Feige, H. Koutnikova, M. F. Champy, N. Dali-Youcef, E. E. Schadt, M. Laakso, and J. Auwerx. 2009. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface. Cell Metab. 9: 88-98.
27. Mohlke, K. L., and M. Boehnke. 2015. Recent advances in understanding the genetic architecture of type 2 diabetes. Hum. Mol. Genet. 24: R85-R92.
28. Zeggini, E., L. J. Scott, R. Saxena, B. F. Voight, J. L. Marchini, T. Hu, P. I. de Bakker, G. R. Abecasis, P. Almgren, G. Andersen, et al. 2008. Meta-Analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40: 638-645.
29. Lyssenko, V., C. L. Nagorny, M. R. Erdos, N. Wierup, A. Jonsson, P. Spegel, M. Bugliani, R. Saxena, M. Fex, N. Pulizzi, et al. 2009. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 41: 82-88.
30. Voight, B. F., L. J. Scott, V. Steinthorsdottir, A. P. Morris, C. Dina, R. P. Welch, E. Zeggini, C. Huth, Y. S. Aulchenko, G. Thorleifsson, et al. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42: 579-589.
31. Morris, A. P., B. F. Voight, T. M. Teslovich, T. Ferreira, A. V. Segre, V. Steinthorsdottir, R. J. Strawbridge, H. Khan, H. Grallert, A. Mahajan, et al. 2012. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44: 981-990.
32. DIAbetes Genetics Replication And Meta-Analysis (DIAGRAM) Consortium; Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium; South Asian Type 2 Diabetes (SAT2D) Consortium; Mexican American Type 2 Diabetes (MAT2D) Consortium; Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples (T2D-GENES) Consortium, A. Mahajan, M. J. Go, W. Zhang, J. E. Below, K. J. Gaulton, et al. 2014. Genome-wide trans-Ancestry meta-Analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46: 234-244.
33. Prokopenko, I., W. Poon, R. Magi, B. R. Prasad, S. A. Salehi, P. Almgren, P. Osmark, N. Bouatia-Naji, N. Wierup, T. Fall, et al. 2014. A central role for GRB10 in regulation of islet function in man. PLoS Genet. 10: E1004235.
34. Gaulton, K. J., T. Ferreira, Y. Lee, A. Raimondo, R. Magi, M. E. Reschen, A. Mahajan, A. Locke, N. W. Rayner, N. Robertson, et al. 2015. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47: 1415-1425.
35. Flannick, J., G. Thorleifsson, N. L. Beer, S. B. Jacobs, N. Grarup, N. P. Burtt, A. Mahajan, C. Fuchsberger, G. Atzmon, R. Benediktsson, et al. 2014. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat. Genet. 46: 357-363.
36. Steinthorsdottir, V., G. Thorleifsson, P. Sulem, H. Helgason, N. Grarup, A. Sigurdsson, H. T. Helgadottir, H. Johannsdottir, O. T. Magnusson, S. A. Gudjonsson, et al. 2014. Identification of lowfrequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 46: 294-298.
37. Yaghootkar, H., A. Stancakova, R. M. Freathy, J. Vangipurapu, M. N. Weedon, W. Xie, A. R. Wood, E. Ferrannini, A. Mari, S. M. Ring, et al. 2015. Association analysis of 29, 956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. Diabetes. 64: 2279-2285.
38. Scott, R. A., D. F. Freitag, L. Li, A. Y. Chu, P. Surendran, R. Young, N. Grarup, A. Stancakova, Y. Chen, T. V. Varga, et al. 2016. A genomic approach to therapeutic target validation identifies a glucose- lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8: 341-76.
39. Fuchsberger, C., J. Flannick, T. M. Teslovich, A. Mahajan, V. Agarwala, K. J. Gaulton, C. Ma, P. Fontanillas, L. Moutsianas, D. J. McCarthy, et al. 2016. The genetic architecture of type 2 diabetes. Nature. 536: 41-47.
40. Chen, W. M., M. R. Erdos, A. U. Jackson, R. Saxena, S. Sanna, K. D. Silver, N. J. Timpson, T. Hansen, M. Orru, M. Grazia Piras, et al. 2008. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J. Clin. Invest. 118: 2620-2628.
41. Prokopenko, I., C. Langenberg, J. C. Florez, R. Saxena, N. Soranzo, G. Thorleifsson, R. J. Loos, A. K. Manning, A. U. Jackson, Y. Aulchenko, et al. 2009. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 41: 77-81.
42. Li, X., Y. H. Shu, A. H. Xiang, E. Trigo, J. Kuusisto, J. Hartiala, A. J. Swift, M. Kawakubo, H. M. Stringham, L. L. Bonnycastle, et al. 2009. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose. Diabetes. 58: 2946-2953.
43. Dupuis, J., C. Langenberg, I. Prokopenko, R. Saxena, N. Soranzo, A. U. Jackson, E. Wheeler, N. L. Glazer, N. Bouatia-Naji, A. L. Gloyn, et al. 2010. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42: 105-116.
44. Wessel, J., A. Y. Chu, S. M. Willems, S. Wang, H. Yaghootkar, J. A. Brody, M. Dauriz, M. F. Hivert, S. Raghavan, L. Lipovich, et al. 2015. Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat. Commun. 6: 5897.
45. Mahajan, A., X. Sim, H. J. Ng, A. Manning, M. A. Rivas, H. M. Highland, A. E. Locke, N. Grarup, H. K. Im, P. Cingolani, et al. 2015. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 11: E1004876.
46. Saxena, R., M. F. Hivert, C. Langenberg, T. Tanaka, J. S. Pankow, P. Vollenweider, V. Lyssenko, N. Bouatia-Naji, J. Dupuis, A. U. Jackson, et al. 2010. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 42: 142-148.
47. Scott, R. A., A. Y. Chu, N. Grarup, A. K. Manning, M. F. Hivert, D. Shungin, A. Tonjes, A. Yesupriya, D. Barnes, N. Bouatia-Naji, et al. 2012. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 61: 1291-1296.
48. Soranzo, N., S. Sanna, E. Wheeler, C. Gieger, D. Radke, J. Dupuis, N. Bouatia-Naji, C. Langenberg, I. Prokopenko, E. Stolerman, et al. 2010. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes. 59: 3229-3239. [Erratum. 2011. Diabetes. 60: 1050-1051.].
49. Ingelsson, E., C. Langenberg, M. F. Hivert, I. Prokopenko, V. Lyssenko, J. Dupuis, R. Magi, S. Sharp, A. U. Jackson, T. L. Assimes, et al. 2010. Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 59: 1266-1275.
50. Koeck, T., A. H. Olsson, M. D. Nitert, V. V. Sharoyko, C. Ladenvall, O. Kotova, E. Reiling, T. Ronn, H. Parikh, J. Taneera, et al. 2011. A common variant in TFB1M is associated with reduced insulin secretion and increased future risk of type 2 diabetes. Cell Metab. 13: 80-91.
51. Dimas, A. S., V. Lagou, A. Barker, J. W. Knowles, R. Magi, M. F. Hivert, A. Benazzo, D. Rybin, A. U. Jackson, H. M. Stringham, et al. 2014. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes. 63: 2158-2171.
52. Stancáková, A., T. Kuulasmaa, J. Paananen, A. U. Jackson, L. L. Bonnycastle, F. S. Collins, M. Boehnke, J. Kuusisto, and M. Laakso. 2009. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5, 327 nondiabetic Finnish men. Diabetes. 58: 2129-2136.
53. Manning, A. K., M. F. Hivert, R. A. Scott, J. L. Grimsby, N. Bouatia- Naji, H. Chen, D. Rybin, C. T. Liu, L. F. Bielak, I. Prokopenko, et al. 2012. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44: 659-669.
54. Scott, R. A., V. Lagou, R. P. Welch, E. Wheeler, M. E. Montasser, J. Luan, R. Magi, R. J. Strawbridge, E. Rehnberg, S. Gustafsson, et al. 2012. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44: 991-1005.
55. Walford, G. A., S. Gustafsson, D. Rybin, A. Stancakova, H. Chen, C. T. Liu, J. Hong, R. A. Jensen, K. Rice, A. P. Morris, et al. 2016. Genome-wide association study of the modified Stumvoll Insulin Sensitivity Index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes. 65: 3200-3211.
56. Kulzer, J. R., M. L. Stitzel, M. A. Morken, J. R. Huyghe, C. Fuchsberger, J. Kuusisto, M. Laakso, M. Boehnke, F. S. Collins, and K. L. Mohlke. 2014. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am. J. Hum. Genet. 94: 186-197.
57. van de Bunt, M., J. E. Manning Fox, X. Dai, A. Barrett, C. Grey, L. Li, A. J. Bennett, P. R. Johnson, R. V. Rajotte, K. J. Gaulton, et al. 2015. Transcript expression data from human islets links regulatory signals from genome-wide association studies for type 2 diabetes and glycemic traits to their downstream effectors. PLoS Genet. 11: E1005694.
58. Delude, C. M. 2015. Deep phenotyping: The details of disease. Nature. 527: S14-S15.
59. Pal, A., T. M. Barber, M. Van de Bunt, S. A. Rudge, Q. Zhang, K. L. Lachlan, N. S. Cooper, H. Linden, J. C. Levy, M. J. Wakelam, et al. 2012. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N. Engl. J. Med. 367: 1002-1011.
60. Farooqi, I. S., and S. O'Rahilly. 2007. Genetic factors in human obesity. Obes. Rev. 8(Suppl 1): 37-40.
61. Wood, A. R., T. Esko, J. Yang, S. Vedantam, T. H. Pers, S. Gustafsson, A. Y. Chu, K. Estrada, J. Luan, Z. Kutalik, et al. 2014. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46: 1173-1186.
62. Joshi, P. K., T. Esko, H. Mattsson, N. Eklund, I. Gandin, T. Nutile, A. U. Jackson, C. Schurmann, A. V. Smith, W. Zhang, et al. 2015. Directional dominance on stature and cognition in diverse human populations. Nature. 523: 459-462.
63. Willer, C. J., E. K. Speliotes, R. J. Loos, S. Li, C. M. Lindgren, I. M. Heid, S. I. Berndt, A. L. Elliott, A. U. Jackson, C. Lamina, et al. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41: 25-34.
64. Speliotes, E. K., C. J. Willer, S. I. Berndt, K. L. Monda, G. Thorleifsson, A. U. Jackson, H. Lango Allen, C. M. Lindgren, J. Luan, R. Magi, et al. 2010. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42: 937-948.
65. Berndt, S. I., S. Gustafsson, R. Magi, A. Ganna, E. Wheeler, M. F. Feitosa, A. E. Justice, K. L. Monda, D. C. Croteau-Chonka, F. R. Day, et al. 2013. Genome-wide meta-Analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45: 501-512.
66. Locke, A. E., B. Kahali, S. I. Berndt, A. E. Justice, T. H. Pers, F. R. Day, C. Powell, S. Vedantam, M. L. Buchkovich, J. Yang, et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature. 518: 197-206.
67. Lindgren, C. M., I. M. Heid, J. C. Randall, C. Lamina, V. Steinthorsdottir, L. Qi, E. K. Speliotes, G. Thorleifsson, C. J. Willer, B. M. Herrera, et al. 2009. Genome-wide association scan metaanalysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet. 5: E1000508.
68. Heid, I. M., A. U. Jackson, J. C. Randall, T. W. Winkler, L. Qi, V. Steinthorsdottir, G. Thorleifsson, M. C. Zillikens, E. K. Speliotes, R. Magi, et al. 2010. Meta-Analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42: 949-960.
69. Kilpeläinen, T. O., M. C. Zillikens, A. Stancakova, F. M. Finucane, J. S. Ried, C. Langenberg, W. Zhang, J. S. Beckmann, J. Luan, L. Vandenput, et al. 2011. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43: 753-760.
70. Shungin, D., T. W. Winkler, D. C. Croteau-Chonka, T. Ferreira, A. E. Locke, R. Magi, R. J. Strawbridge, T. H. Pers, K. Fischer, A. E. Justice, et al. 2015. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 518: 187-196.
71. Lu, Y., F. R. Day, S. Gustafsson, M. L. Buchkovich, J. Na, V. Bataille, D. L. Cousminer, Z. Dastani, A. W. Drong, T. Esko, et al. 2016. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat. Commun. 7: 10495.
72. Soininen, P., A. J. Kangas, P. Wurtz, T. Suna, and M. Ala-Korpela. 2015. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 8: 192-206.
73. Kathiresan, S., C. J. Willer, G. M. Peloso, S. Demissie, K. Musunuru, E. E. Schadt, L. Kaplan, D. Bennett, Y. Li, T. Tanaka, et al. 2009. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41: 56-65.
74. Wu, Y., L. L. Waite, A. U. Jackson, W. H. Sheu, S. Buyske, D. Absher, D. K. Arnett, E. Boerwinkle, L. L. Bonnycastle, C. L. Carty, et al. 2013. Trans-ethnic fine-mapping of lipid loci identifies population- specific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet. 9: E1003379.
75. Global Lipids Genetics Consortium, C. J. Willer, E. M. Schmidt, S. Sengupta, G. M. Peloso, S. Gustafsson, S. Kanoni, A. Ganna, J. Chen, M. L. Buchkovich, et al. 2013. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45: 1274-1283.
76. Haas, B. E., D. Weissglas-Volkov, C. A. Aguilar-Salinas, E. Nikkola, L. Vergnes, I. Cruz-Bautista, L. Riba, A. Stancakova, J. Kuusisto, P. Soininen, et al. 2011. Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles. Arterioscler. Thromb. Vasc. Biol. 31: 1201-1207.
77. Roman, T. S., A. F. Marvelle, M. P. Fogarty, S. Vadlamudi, A. J. Gonzalez, M. L. Buchkovich, J. R. Huyghe, C. Fuchsberger, A. U. Jackson, Y. Wu, et al. 2015. Multiple hepatic regulatory variants at the GALNT2 GWAS locus associated with high-density lipoprotein cholesterol. Am. J. Hum. Genet. 97: 801-815.
78. Rodríguez, A., L. Gonzalez, A. Ko, M. Alvarez, Z. Miao, Y. Bhagat, E. Nikkola, I. Cruz-Bautista, O. Arellano-Campos, L. L. Munoz- Hernandez, et al. 2016. Molecular characterization of the lipid genome-wide association study signal on chromosome 18q11.2 implicates HNF4A-mediated regulation of the TMEM241 gene. Arterioscler. Thromb. Vasc. Biol. 36: 1350-1355.
79. Newton-Cheh, C., T. Johnson, V. Gateva, M. D. Tobin, M. Bochud, L. Coin, S. S. Najjar, J. H. Zhao, S. C. Heath, S. Eyheramendy, et al. 2009. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41: 666-676.
80. International Consortium for Blood Pressure Genome-Wide Association Studies, G. B. Ehret, P. B. Munroe, K. M. Rice, M. Bochud, A. D. Johnson, D. I. Chasman, A. V. Smith, M. D. Tobin, G. C. Verwoert, et al. 2011. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 478: 103-109.
81. Fox, E. R., J. H. Young, Y. Li, A. W. Dreisbach, B. J. Keating, S. K. Musani, K. Liu, A. C. Morrison, S. Ganesh, A. Kutlar, et al. 2011. Association of genetic variation with systolic and diastolic blood pressure among African Americans: The Candidate Gene Association Resource study. Hum. Mol. Genet. 20: 2273-2284.
82. Surendran, P., F. Drenos, R. Young, H. Warren, J. P. Cook, A. K. Manning, N. Grarup, X. Sim, D. R. Barnes, K. Witkowska, et al. 2016. Trans-Ancestry meta-Analyses identify novel rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48: 1151-1161.
83. Kristiansson, K., M. Perola, E. Tikkanen, J. Kettunen, I. Surakka, A. S. Havulinna, A. Stancakova, C. Barnes, E. Widen, E. Kajantie, et al. 2012. Genome-wide screen for metabolic syndrome susceptibility Loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circ Cardiovasc Genet. 5: 242-249.
84. Hirschey, M. D., T. Shimazu, E. Jing, C. A. Grueter, A. M. Collins, B. Aouizerat, A. Stancakova, E. Goetzman, M. M. Lam, B. Schwer, et al. 2011. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell. 44: 177-190.
85. Dastani, Z., M. F. Hivert, N. Timpson, J. R. Perry, X. Yuan, R. A. Scott, P. Henneman, I. M. Heid, J. R. Kizer, L. P. Lyytikainen, et al. 2012. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-Analysis of 45, 891 individuals. PLoS Genet. 8: E1002607.
86. Yaghootkar, H., C. Lamina, R. A. Scott, Z. Dastani, M. F. Hivert, L. L. Warren, A. Stancakova, S. G. Buxbaum, L. P. Lyytikainen, P. Henneman, et al. 2013. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 62: 3589-3598.
87. CARDIoGRAMplusC4D Consortium, P. Deloukas, S. Kanoni, C. Willenborg, M. Farrall, T. L. Assimes, J. R. Thompson, E. Ingelsson, D. Saleheen, J. Erdmann, et al. 2013. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45: 25-33.
88. Do, R., C. J. Willer, E. M. Schmidt, S. Sengupta, C. Gao, G. M. Peloso, S. Gustafsson, S. Kanoni, A. Ganna, J. Chen, et al. 2013. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45: 1345-1352.
89. Edwards, S. L., J. Beesley, J. D. French, and A. M. Dunning. 2013. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93: 779-797.
90. Emilsson, V., G. Thorleifsson, B. Zhang, A. S. Leonardson, F. Zink, J. Zhu, S. Carlson, A. Helgason, G. B. Walters, S. Gunnarsdottir, et al. 2008. Genetics of gene expression and its effect on disease. Nature. 452: 423-428.
91. Civelek, M., Y. Wu, C. Pan, C. K. Raulerson, A. Ko, A. He, C. Tilford, N. K. Saleem, A. Stančáková, L. J. Scott, et al. 2017. Genetic regulation of adipose gene expression and cardio-metabolic traits. Am. J. Hum. Genet. In press.
92. Lusis, A. J., M. M. Seldin, H. Allayee, B. J. Bennett, M. Civelek, R. C. Davis, E. Eskin, C. R. Farber, S. Hui, M. Mehrabian, et al. 2016. The Hybrid Mouse Diversity Panel: A resource for systems genetics analyses of metabolic and cardiovascular traits. J. Lipid Res. 57: 925-942.
93. Rau, C. D., M. Civelek, C. Pan, and A. J. Lusis. 2017. A suite of tools for biologists that improve accessibility and visualization of large systems genetics datasets: Applications to the Hybrid Mouse Diversity Panel. Methods Mol. Biol. 1488: 153-188.
94. Civelek, M., R. Hagopian, C. Pan, N. Che, W. P. Yang, P. S. Kayne, N. K. Saleem, H. Cederberg, J. Kuusisto, P. S. Gargalovic, et al. 2013. Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits. Hum. Mol. Genet. 22: 3023-3037.
95. Davey Smith, G., and G. Hemani. 2014. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23: R89-R98.
96. Walther, T. C., and M. Mann. 2010. Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 190: 491-500.
97. Sonnenburg, J. L., and F. Backhed. 2016. Diet-microbiota interactions as moderators of human metabolism. Nature. 535: 56-64.
98. Bell, J. T., A. A. Pai, J. K. Pickrell, D. J. Gaffney, R. Pique-Regi, J. F. Degner, Y. Gilad, and J. K. Pritchard. 2011. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 12: R10.
99. American Diabetes Association. Genetics portal for type 2 diabetes debuts. 2015. Accessed June 7, 2015, at http://www.diabetesdispatchextra.org/genetics-portal-for-Type-2-diabetesdebuts.
100. Civelek, M., and A. J. Lusis. 2014. Systems genetics approaches to understand complex traits. Nat. Rev. Genet. 15: 34-48.